Page last updated: 2024-10-20

trimethyloxamine and ER-Negative PR-Negative HER2-Negative Breast Cancer

trimethyloxamine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

trimethyloxamine: used in manufacture of quaternary ammonium cpds; insect attractant; warming agent for gas; oxidant; structure
trimethylamine N-oxide : A tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wang, H1
Rong, X1
Zhao, G1
Zhou, Y2
Xiao, Y1
Ma, D1
Jin, X1
Wu, Y1
Yan, Y1
Yang, H1
Qian, M1
Niu, C1
Hu, X1
Li, DQ1
Liu, Q1
Wen, Y1
Jiang, YZ1
Zhao, C1
Shao, ZM1

Other Studies

1 other study available for trimethyloxamine and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer.
    Cell metabolism, 2022, 04-05, Volume: 34, Issue:4

    Topics: Choline; Humans; Methylamines; Microbiota; Triple Negative Breast Neoplasms; Tumor Microenvironment

2022